1. Abbott

    0 Comments Leave a Comment

    1-15 of 906 1 2 3 4 ... 59 60 61 »
    1. Mentioned In 906 Articles

    2. Differences in Culprit Lesions Between Pre-menopausal and Postmenopausal Women with Acute Coronary Syndrome: An Optical Coherence Tomography Study

      Differences in Culprit Lesions Between Pre-menopausal and Postmenopausal Women with Acute Coronary Syndrome: An Optical Coherence Tomography Study
      ... predilatation was not used. The frequency-domain OCT C7 system and the Dragon Fly catheter (Lightlab Imaging/St. Jude Medical, Westford, Massachusetts, USA) were used for acquiring OCT images. With the C7 system, a 2.7-...
      Read Full Article
    3. The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease

      The Impact of Optical Coherence Tomography on the Endovascular Treatment Planning of Femoropopliteal Disease
      Rationale: Peripheral arterial disease is a severe clinical problem with an increasing prevalence, due to an ageing population. Endovascular treatment, usually using stents, is recommended for most lesions in the femoropopliteal tract. The patency of these stents is influenced by several factors, including stent sizing and stent positioning. Current procedural planning of femoropopliteal disease is primarily based on single-plane digital subtraction angiographies (DSA). This modality provides a 2-dimensional image of ...
      Read Full Article
    4. Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study

      Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study
      ...he culprit lesion were acquired using the frequency-domain ILUMIEN OPTIS OCT system and a dragonfly catheter (St. Jude Medical, Westford, MA, USA). All OCT images were analyzed and scrutinized using St Jude OCT Offline R...
      Read Full Article
    5. Comparison of 6‐month vascular healing response after bioresorbable polymer versus durable polymer drug‐eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study

      Comparison of 6‐month vascular healing response after bioresorbable polymer versus durable polymer drug‐eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study
      ...ickness; Boston Scientific Corporation, Marlborough, MA) versus DP-EES (XIENCE Alpine, 81 μm strut thickness; Abbott Vascular, Santa Clara, CA) using a web-based randomization system after restoration of TIMI 3 flow, but...
      Read Full Article
    6. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold

      Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold
      ...rvention (PCI) with implantation of everolimus-eluting bioresorbable vascular scaffold (BVS) (ABSORB BVS 1.0, Abbott Vascular) are limited. The mechanisms underlying very late scaffold failure remain to be further elucid...
      Read Full Article
      Mentions: Abbott
    7. 1-15 of 906 1 2 3 4 ... 59 60 61 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Abbott

    Abbott

    Abbott has cardiovascular and ophthalmic OCT.  (Abbot acquired St. Jude Medical, which acquired Lightlab Imaging).

  3. Quotes about Abbott

    1. OptiMedica's technology, combined with Abbott's global market presence, offers the potential to provide advanced cataract treatment options to more patients around the world.
      In Abbott completes $400M OptiMedica deal
    2. Surgeons should have the choice of the best and most innovative products to maximize clinical outcomes, manage their data, and optimize their workflow...That is why we agreed to expand our customer reach in the United States by making our products available additionally through Abbott.
      In Abbott Expands Cataract Surgery Product Portfolio through U.S. Distribution Agreement with Carl Zeiss Meditec